Biophysical Analysis of the Protein-Small Molecule Interactions to Develop Small Molecule Drug Discovery

被引:1
作者
Nagatoishi, Satoru [1 ]
Caaveiro, Jose M. M. [1 ]
Tsumoto, Kouhei [1 ,2 ,3 ]
机构
[1] Univ Tokyo, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan
[2] Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan
[3] Univ Tokyo, Drug Discovery Initiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2018年 / 138卷 / 08期
基金
日本学术振兴会;
关键词
drug discovery; small molecule screening; biophysical analysis; surface plasmon resonance; isothermal titration calorimetry;
D O I
10.1248/yakushi.17-00211-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In small molecule drug discovery, researchers must find specific binders that interact with a target protein and inhibit its function in connection with human diseases. It is of critical importance to know the binding mode of compounds interacting with a target protein to assure hit validation and optimization. Biophysical analysis is a powerful quantitative approach to evaluate the binding modes of such candidates. Since the level of sensitivity of biophysical analysis is suitable to quantitatively detect the binding of fragment compounds, and because of the remarkable success of compound libraries of small molecules, the development and adaptation of biophysical analysis for these applications is in great demand. Herein, we describe the technical developments of biophysical methods, especially thermodynamic and kinetic analysis, for the purpose of screenings which employ small molecules. In addition, we discuss the interaction mechanisms of small molecules to find hit compounds based on these biophysical analyses.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 15 条
[1]  
Barbour R, 2012, BIOANALYSIS, V4, P619, DOI [10.4155/bio.12.45, 10.4155/BIO.12.45]
[2]  
Ciulli Alessio, 2013, Methods Mol Biol, V1008, P357, DOI 10.1007/978-1-62703-398-5_13
[3]  
Damian Luminita, 2013, Methods Mol Biol, V1008, P103, DOI 10.1007/978-1-62703-398-5_4
[4]   Integrating biophysics with HTS-driven drug discovery projects [J].
Folmer, Rutger H. A. .
DRUG DISCOVERY TODAY, 2016, 21 (03) :491-498
[5]  
Frostell Asa, 2013, Methods Mol Biol, V1008, P139, DOI 10.1007/978-1-62703-398-5_6
[6]   FROM EXPERIMENTAL DESIGN TO VALIDATED HITS: A COMPREHENSIVE WALK-THROUGH OF FRAGMENT LEAD IDENTIFICATION USING SURFACE PLASMON RESONANCE [J].
Giannetti, Anthony M. .
FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 :169-218
[7]  
Holdgate Geoffrey, 2013, Methods Mol Biol, V1008, P327, DOI 10.1007/978-1-62703-398-5_12
[8]   Incorporation of Rapid Thermodynamic Data in Fragment-Based Drug Discovery [J].
Kobe, Akihiro ;
Caaveiro, Jose M. M. ;
Tashiro, Shinya ;
Kajihara, Daisuke ;
Kikkawa, Masato ;
Mitani, Tomoya ;
Tsumoto, Kouhei .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) :2155-2159
[9]  
Kuo LC, 2011, METHOD ENZYMOL, V493, P1
[10]   Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus [J].
Nakano, Koichiro ;
Chigira, Takeru ;
Miyafusa, Takamitsu ;
Nagatoishi, Satoru ;
Caaveiro, Jose M. M. ;
Tsumoto, Kouhei .
SCIENTIFIC REPORTS, 2015, 5